Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study | NEJM - nejm.org

Original Article from The New England Journal of Medicine — Vaccine Efficacy in Adults in a Respiratory Syncytial Virus Challenge Study

Background Although human respiratory syncytial virus (RSV) is an important cause of illness and death in older adults, no RSV vaccine has been licensed. Methods Download a PDF of the Research Sum… [+2159 chars]

full article...